Answers are grounded in this paper and cite their sources.
In the last two decades, transporters attracted much attention in identification of potential drug targetsagainst intracellular protozoa. Several membrane molecules exhibit essential roles in trafficking pathwaysfor nutrients, essential enzymes and virulence factors. In this context, P. falciparum possesses a complexof genomic plasticity-encoding transporters with high potentiality for aneuploidy, and gene expressionmodulation in response to drug exposure. Therefore, it is able to undergo gene mutations in enzymes controllingdrug uptake, and evade host immune response by antigenic variations as well. The genetic mechanism ofantimalarial drug resistance arises early with monotherapy using fast-acting drugs or a single targeting drug.Accordingly, combined therapy acting on multiple targets would decrease the emergence of drug resistance.Evolutionary technology on genetic approach enabled researchers to identify and propose novel Plasmodiumdrug targets. The main objective of this part is to review potential drug targets for apicomplexans and discussrecent approaches in identifying Plasmodium targets, as well as advances in the design and development ofnovel antimalarial drugs.
No takes yet. Share an insight, caveat, or question.
Sherif Abaza (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: